ATE429229T1 - Indol-, azaindol- und verwandte heterozyklische amidopiperazin-derivate - Google Patents
Indol-, azaindol- und verwandte heterozyklische amidopiperazin-derivateInfo
- Publication number
- ATE429229T1 ATE429229T1 AT02764315T AT02764315T ATE429229T1 AT E429229 T1 ATE429229 T1 AT E429229T1 AT 02764315 T AT02764315 T AT 02764315T AT 02764315 T AT02764315 T AT 02764315T AT E429229 T1 ATE429229 T1 AT E429229T1
- Authority
- AT
- Austria
- Prior art keywords
- azaindole
- heteroaryl
- group
- indole
- related heterocyclic
- Prior art date
Links
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title abstract 3
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 title abstract 2
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 title abstract 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 title abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 3
- 229910052760 oxygen Inorganic materials 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 1
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 125000002619 bicyclic group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 150000002475 indoles Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28634701P | 2001-04-25 | 2001-04-25 | |
| PCT/US2002/012856 WO2002085301A2 (en) | 2001-04-25 | 2002-04-23 | Indole, azaindole and related heterocyclic amidopiperazine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE429229T1 true ATE429229T1 (de) | 2009-05-15 |
Family
ID=23098194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02764315T ATE429229T1 (de) | 2001-04-25 | 2002-04-23 | Indol-, azaindol- und verwandte heterozyklische amidopiperazin-derivate |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6825201B2 (de) |
| EP (1) | EP1381366B9 (de) |
| JP (1) | JP4326221B2 (de) |
| CN (1) | CN1330307C (de) |
| AT (1) | ATE429229T1 (de) |
| BR (1) | BR0209153A (de) |
| CA (1) | CA2445190C (de) |
| CY (1) | CY1109219T1 (de) |
| DE (1) | DE60232065D1 (de) |
| DK (1) | DK1381366T3 (de) |
| ES (1) | ES2323859T3 (de) |
| HU (1) | HU230215B1 (de) |
| MX (1) | MXPA03009680A (de) |
| PT (1) | PT1381366E (de) |
| WO (1) | WO2002085301A2 (de) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040110785A1 (en) * | 2001-02-02 | 2004-06-10 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| HU229305B1 (en) * | 2001-02-02 | 2013-10-28 | Bristol Myers Squibb Co | Antiviral substituted azaindoleoxoacetic piperazine dervatives and compositions thereof |
| US6900206B2 (en) * | 2002-06-20 | 2005-05-31 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives |
| US20050075364A1 (en) * | 2003-07-01 | 2005-04-07 | Kap-Sun Yeung | Indole, azaindole and related heterocyclic N-substituted piperazine derivatives |
| AP2006003514A0 (en) * | 2003-08-14 | 2006-02-28 | Pfizer | Piperazine derivatives for the treatment of HIV infections. |
| EP1689383B1 (de) * | 2003-11-19 | 2012-10-31 | Metabasis Therapeutics, Inc. | Neue phosphor enthaltende thyromimetika |
| US20050124623A1 (en) | 2003-11-26 | 2005-06-09 | Bender John A. | Diazaindole-dicarbonyl-piperazinyl antiviral agents |
| US7772271B2 (en) * | 2004-07-14 | 2010-08-10 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| US7868037B2 (en) * | 2004-07-14 | 2011-01-11 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| EA200700243A1 (ru) * | 2004-07-14 | 2007-08-31 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | Способы лечения гепатита с |
| US7781478B2 (en) * | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| JP2008507518A (ja) * | 2004-07-22 | 2008-03-13 | ピーティーシー セラピューティクス，インコーポレーテッド | Ｃ型肝炎を治療するためのチエノピリジン |
| ATE527258T1 (de) * | 2004-07-28 | 2011-10-15 | Takeda Pharmaceutical | Pyrroloä2,3-cüpyridinverbindung, verfahren zu deren herstellung und anwendung |
| CA2583409C (en) | 2004-09-17 | 2014-06-17 | Idenix Pharmaceuticals, Inc. | Phospho-indoles as hiv inhibitors |
| US20060100432A1 (en) * | 2004-11-09 | 2006-05-11 | Matiskella John D | Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione |
| US20060100209A1 (en) * | 2004-11-09 | 2006-05-11 | Chong-Hui Gu | Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione |
| US7183284B2 (en) | 2004-12-29 | 2007-02-27 | Bristol-Myers Squibb Company | Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents |
| WO2006085199A1 (en) * | 2005-02-14 | 2006-08-17 | Pfizer Limited | Piperazine derivatives |
| CA2606499C (en) | 2005-05-26 | 2017-06-13 | Metabasis Therapeutics, Inc. | Thyromimetics for the treatment of fatty liver diseases |
| AU2006264170A1 (en) * | 2005-06-27 | 2007-01-04 | Ambrilia Biopharma Inc. | Pyrazolo[3,4-b]pyridin-2-yl)-benzoic acid derivatives as HIV integrase inhibitors |
| JP2009502859A (ja) | 2005-07-29 | 2009-01-29 | エフ．ホフマン−ラ ロシュ アーゲー | インドール−３−イル−カルボニル−ピペリジン及びピペラジン誘導体 |
| US7598380B2 (en) * | 2005-08-03 | 2009-10-06 | Bristol-Myers Squibb Company | Method of preparation of azaindole derivatives |
| US7851476B2 (en) * | 2005-12-14 | 2010-12-14 | Bristol-Myers Squibb Company | Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine |
| US7807671B2 (en) * | 2006-04-25 | 2010-10-05 | Bristol-Myers Squibb Company | Diketo-piperazine and piperidine derivatives as antiviral agents |
| BRPI0717511A2 (pt) | 2006-09-29 | 2013-11-19 | Idenix Pharmaceuticals Inc | Composto puro, composição farmacêutica, métodos para tratar uma infecção por hiv, para prevenir uma infecção por hiv, para inibir a replicação de hiv, e, uso de um composto |
| TW200946541A (en) * | 2008-03-27 | 2009-11-16 | Idenix Pharmaceuticals Inc | Solid forms of an anti-HIV phosphoindole compound |
| DK2626361T3 (en) | 2008-04-24 | 2015-01-19 | F2G Ltd | Pyrrol-Antimycotics |
| JP5433691B2 (ja) * | 2008-06-25 | 2014-03-05 | ブリストル−マイヤーズ スクイブ カンパニー | Ｈｉｖ結合阻害剤としてのジケトピペリジン誘導体 |
| ES2462403T3 (es) | 2008-06-25 | 2014-05-22 | Bristol-Myers Squibb Company | Diceto azolopiperidinas y azolopiperazinas como agentes anti-VIH |
| SI2323633T1 (sl) * | 2008-09-04 | 2012-07-31 | Bristol Myers Squibb Co | Stabilni farmacevtski sestavek za optimizirano razdeljevanje hiv pripetih inhibitorjev |
| GB0817576D0 (en) * | 2008-09-25 | 2008-11-05 | Lectus Therapeutics Ltd | Calcium ion channel modulators & uses thereof |
| KR20140000275A (ko) * | 2010-11-18 | 2014-01-02 | 예일 유니버시티 | 인체 면역결핍 바이러스에 대해 항체 모집 및 진입 저해 활성을 갖는 2작용기의 분자 |
| EP2696937B1 (de) | 2011-04-12 | 2017-05-17 | VIIV Healthcare UK (No.5) Limited | Thioamid-, amidoxim- und amidrazonderivate als hiv-bindungsinhibitoren |
| US8664213B2 (en) | 2011-08-29 | 2014-03-04 | Bristol-Myers Squibb Company | Spiro bicyclic diamine derivatives as HIV attachment inhibitors |
| EP2751119B1 (de) | 2011-08-29 | 2016-11-23 | VIIV Healthcare UK (No.5) Limited | Kondensierte bicyclische diaminderivate als hiv-anhaftungshemmer |
| WO2013138436A1 (en) | 2012-03-14 | 2013-09-19 | Bristol-Myers Squibb Company | Cyclolic hydrazine derivatives as hiv attachment inhibitors |
| US9505752B2 (en) | 2012-08-09 | 2016-11-29 | Viiv Healthcare Uk (No. 5) Limited | Piperidine amide derivatives as HIV attachment inhibitors |
| EP2895472B1 (de) | 2012-08-09 | 2016-11-23 | VIIV Healthcare UK (No.5) Limited | Trizyklische Alken-Derivate als HIV-Bindungsinhibitoren |
| WO2014160692A1 (en) * | 2013-03-27 | 2014-10-02 | Bristol-Myers Squibb Company | 2-keto amide derivatives as hiv attachment inhibitors |
| JP2016515579A (ja) * | 2013-03-27 | 2016-05-30 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | Ｈｉｖ結合阻害剤としてのピペラジンおよびホモピペラジン誘導体 |
| JP6681894B2 (ja) | 2014-11-21 | 2020-04-15 | エフツージー リミテッド | 抗真菌剤 |
| WO2017144624A1 (en) * | 2016-02-23 | 2017-08-31 | Servicio Andaluz De Salud | Piperazine derivatives as antiviral agents with increased therapeutic activity |
| GB201609222D0 (en) | 2016-05-25 | 2016-07-06 | F2G Ltd | Pharmaceutical formulation |
| EP3541395A4 (de) | 2016-11-21 | 2020-07-01 | Viking Therapeutics, Inc. | Verfahren zur behandlung einer glykogenspeicherkrankheit |
| WO2018118838A1 (en) * | 2016-12-20 | 2018-06-28 | Biomarin Pharmaceutical Inc. | Ceramide galactosyltransferase inhibitors for the treatment of disease |
| EP3634426A4 (de) | 2017-06-05 | 2021-04-07 | Viking Therapeutics, Inc. | Zusammensetzungen zur behandlung von fibrose |
| CN109154016B (zh) * | 2017-12-29 | 2021-11-16 | 邦泰生物工程(深圳)有限公司 | 一种化学-酶法制备熊去氧胆酸的方法 |
| KR20200138283A (ko) | 2018-03-22 | 2020-12-09 | 바이킹 테라퓨틱스 인코포레이티드 | 결정질 형태, 및 결정질 형태의 화합물을 제조하는 방법 |
| CN108794559A (zh) * | 2018-07-31 | 2018-11-13 | 重庆波克底科技开发有限责任公司 | 一种以猪去氧胆酸为原料合成石胆酸的方法 |
| EP3890747A4 (de) | 2018-12-05 | 2022-08-03 | Viking Therapeutics, Inc. | Zusammensetzungen zur behandlung von fibrose und entzündungen |
| US11819503B2 (en) | 2019-04-23 | 2023-11-21 | F2G Ltd | Method of treating coccidioides infection |
| CN114981247A (zh) * | 2019-11-22 | 2022-08-30 | 卫材R&D管理有限公司 | 用于抑制cps1的哌嗪化合物 |
| US20210246140A1 (en) * | 2020-01-31 | 2021-08-12 | The General Hospital Corporation | Modulators of metabotropic glutamate receptor 2 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8615562D0 (en) | 1986-06-25 | 1986-07-30 | Maggioni Farma | Aminoalcohols |
| US5023265A (en) | 1990-06-01 | 1991-06-11 | Schering Corporation | Substituted 1-H-pyrrolopyridine-3-carboxamides |
| ATE148464T1 (de) | 1991-07-03 | 1997-02-15 | Upjohn Co | Substituierte indole als anti-aids pharmaceutische zubereitungen |
| US5124327A (en) | 1991-09-06 | 1992-06-23 | Merck & Co., Inc. | HIV reverse transcriptase |
| WO1993005020A1 (en) | 1991-09-06 | 1993-03-18 | Merck & Co., Inc. | Indoles as inhibitors of hiv reverse transcriptase |
| IT1265057B1 (it) | 1993-08-05 | 1996-10-28 | Dompe Spa | Tropil 7-azaindolil-3-carbossiamidi |
| US5424329A (en) | 1993-08-18 | 1995-06-13 | Warner-Lambert Company | Indole-2-carboxamides as inhibitors of cell adhesion |
| GB9420521D0 (en) | 1994-10-12 | 1994-11-30 | Smithkline Beecham Plc | Novel compounds |
| DE69719766T2 (de) | 1996-08-29 | 2004-01-15 | Takeda Chemical Industries Ltd | Zyklische etherverbindungen als natriumkanal-modulatoren |
| KR20010082184A (ko) * | 1998-08-28 | 2001-08-29 | 추후제출 | p38-α 키나제의 저해체 |
| GB9905010D0 (en) | 1999-03-04 | 1999-04-28 | Merck Sharp & Dohme | Therapeutic agents |
| US6469006B1 (en) * | 1999-06-15 | 2002-10-22 | Bristol-Myers Squibb Company | Antiviral indoleoxoacetyl piperazine derivatives |
| US20020061892A1 (en) * | 2000-02-22 | 2002-05-23 | Tao Wang | Antiviral azaindole derivatives |
| US6573262B2 (en) * | 2000-07-10 | 2003-06-03 | Bristol-Myers Sqibb Company | Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives |
| DE60113543T2 (de) * | 2000-07-10 | 2006-07-13 | Bristol-Myers Squibb Co. | Zusammensetzung und antivirale wirkung von substituierten indol-oxo-aceto-piperidin-derivaten |
| US6632810B2 (en) * | 2001-06-29 | 2003-10-14 | Kowa Co., Ltd. | Cyclic diamine compound with condensed-ring groups |
-
2002
- 2002-04-22 US US10/127,256 patent/US6825201B2/en not_active Expired - Lifetime
- 2002-04-23 DE DE60232065T patent/DE60232065D1/de not_active Expired - Lifetime
- 2002-04-23 JP JP2002582877A patent/JP4326221B2/ja not_active Expired - Fee Related
- 2002-04-23 CA CA2445190A patent/CA2445190C/en not_active Expired - Fee Related
- 2002-04-23 DK DK02764315T patent/DK1381366T3/da active
- 2002-04-23 CN CNB028126297A patent/CN1330307C/zh not_active Expired - Fee Related
- 2002-04-23 PT PT02764315T patent/PT1381366E/pt unknown
- 2002-04-23 HU HU0401503A patent/HU230215B1/hu not_active IP Right Cessation
- 2002-04-23 WO PCT/US2002/012856 patent/WO2002085301A2/en not_active Ceased
- 2002-04-23 ES ES02764315T patent/ES2323859T3/es not_active Expired - Lifetime
- 2002-04-23 BR BR0209153-4A patent/BR0209153A/pt active Search and Examination
- 2002-04-23 MX MXPA03009680A patent/MXPA03009680A/es active IP Right Grant
- 2002-04-23 AT AT02764315T patent/ATE429229T1/de active
- 2002-04-23 EP EP02764315A patent/EP1381366B9/de not_active Expired - Lifetime
-
2009
- 2009-06-30 CY CY20091100690T patent/CY1109219T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1520295A (zh) | 2004-08-11 |
| EP1381366B1 (de) | 2009-04-22 |
| EP1381366A2 (de) | 2004-01-21 |
| BR0209153A (pt) | 2004-07-20 |
| US20030096825A1 (en) | 2003-05-22 |
| WO2002085301A2 (en) | 2002-10-31 |
| MXPA03009680A (es) | 2004-02-12 |
| EP1381366A4 (de) | 2005-02-16 |
| CA2445190C (en) | 2011-08-09 |
| US6825201B2 (en) | 2004-11-30 |
| PT1381366E (pt) | 2009-07-21 |
| EP1381366B9 (de) | 2009-10-21 |
| CY1109219T1 (el) | 2014-07-02 |
| JP2004527538A (ja) | 2004-09-09 |
| CN1330307C (zh) | 2007-08-08 |
| JP4326221B2 (ja) | 2009-09-02 |
| ES2323859T3 (es) | 2009-07-27 |
| DK1381366T3 (da) | 2009-08-17 |
| HUP0401503A3 (en) | 2009-06-29 |
| HUP0401503A2 (hu) | 2004-12-28 |
| WO2002085301A3 (en) | 2003-02-27 |
| HU230215B1 (hu) | 2015-10-28 |
| DE60232065D1 (de) | 2009-06-04 |
| CA2445190A1 (en) | 2002-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE429229T1 (de) | Indol-, azaindol- und verwandte heterozyklische amidopiperazin-derivate | |
| BG106390A (en) | Novel spiro compounds | |
| EA200600225A1 (ru) | Производные пиперазина для лечения вич инфекций | |
| DK0591528T3 (da) | Pyrazolo[1,5-a]pyrimidinderivat og antiinflammatorisk middel, der indeholder dette | |
| CA2460572A1 (en) | Dual action antibiotics | |
| DE60204452D1 (de) | Pyrazolo[1,5]pyridinderivate | |
| NO20035583D0 (no) | Imidazo` 1,2-A pyridinderivater for profylakse og behandling av herpes virale infeksjoner | |
| BR0315405A (pt) | Compostos inibidores da integrase tricìclica pré-organizados | |
| DK1140993T3 (da) | Glycopeptidderivater og farmaceutiske præparater indeholdende dem | |
| UA83243C2 (ru) | Соединения, которые ингибируют натриезависимый переносчик глюкозы | |
| BR0213140A (pt) | Fungicidas de pirazol-pirimidina | |
| GEP20074198B (en) | N-aryl-2-oxazolidinone-5-carboxamides and their derivates and their use as antibacterials | |
| ATE402164T1 (de) | Stickstoffhaltige verbindung mit kondensiertem ring und pyrazolylgruppe als substituent und medizinische zusammensetzung davon | |
| DE60212949D1 (de) | Antivirale pyrazolopyridin verbindungen | |
| PT718293E (pt) | Composto ciclodepsipeptidico | |
| ATE380030T1 (de) | Antivirale bicyclo-4.4.0-derivate | |
| DE69510033D1 (de) | Aryl- und heteroaryl- pyrimidine als herbizide | |
| DK1643984T3 (da) | Anvendelse af parthenolidderivater som antileukæmiske og cytotoksske midler | |
| UA85502C2 (en) | Diazaindole-dicarbonyl-piperazinyl antiviral agents | |
| BR0314860A (pt) | Derivados de pirazol | |
| ATE373000T1 (de) | Pyrazolopyridin-derivate als antiherpesmittel | |
| MXPA04007048A (es) | Derivados de amidoacetonitrilo. | |
| ATE274515T1 (de) | Pyrazolopyridinderivate | |
| AR043271A1 (es) | Compuestos de dihidropironas con heterociclos unidos y su uso en composicines farmaceuticas que poseen actividad inhibidora de hiv proteasa | |
| ATE322470T1 (de) | Funktionalisierte höhere diamantoide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1381366 Country of ref document: EP |